Human Clinical Trial to Evaluate the Decolonization Efficacy of BM111 Against Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococcus (VRE)

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Related documents

• Molecular Characterization of Carbapenemase-Producing Enterobacterales#834688
• Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit#349980
• Comparison of Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae#143609
• Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation#411237
• Comparative analysis of biofilm formation in carbapenem-resistant and carbapenem-susceptible Klebsiella pneumoniae clinical isolates from a tertiary hospital in Nigeria: Analyse comparative de la formation de biofilm chez des isolats cliniques de Klebsiella pneumoniae résistants et sensibles aux carbapénèmes provenant d'un hôpital universitaire du Nigéria#1149019